Diagnostic performance of Pictor's targeted proteomics assay for extractable nuclear antigens compared with commercial line immunoassay and addressable laser bead immunoassay platforms.

Published 07/15/2026

Research record: Diagnostic performance of Pictor's targeted proteomics assay for extractable nuclear antigens compared with commercial line immunoassay and addressable laser bead immunoassay platforms.

Published in J Immunol Methods; first publication date 2026-07-15. PMID 42456928.

This literature update records publication metadata from Europe PMC. Consult the original publication for its methods, findings and limitations.

Read the original publication on PubMed

Talk to a Specialist Browse all insights

Review and references

Source

Compiled from public manufacturer materials and regulatory sources. Not independently verified and not reviewed by a named clinician.

Published

2026-07-15

Updated

2026-10-20

Disclaimer

professional use

References